Экономическое бремя сахарного диабета 2-го типа в Российской Федерации: вклад осложнений и роль медицинской реабилитации (аналитический обзор)
Introduction: Type 2 diabetes mellitus (T2DM) represents a major economic burden for healthcare systems. As of 1 January 2026, the Federal Diabetes Register included 5.81 million patients, of whom 5.37 million (92.3%) had T2DM; adjusted for undiagnosed cases, the real prevalence is estimated at 10–12 million. T2DM with...